Brief: Medincell Launches Regulatory Development Of Mdc-WWM Program

Medincell SA

22/04/2020 17:11

April 22 (Reuters) - Medincell SA  MEDCL.PA :
    * MEDINCELL LAUNCHES REGULATORY DEVELOPMENT OF MDC-WWM
PROGRAM
    * HAS DESIGNED, TESTED AND SELECTED WITH SUPPORT OF BILL &
MELINDA
GATES FOUNDATION CANDIDATE FORMULATION WHICH CAN NOW ENTER
PRECLINICAL DEVELOPMENT
    * PRECLINICAL ACTIVITIES AND PHASE 1 CLINICAL STUDIES WILL
BE
FULLY FUNDED BY A UP TO $19 MILLION OVER FOUR YEARS GRANT
    * GRANT IS STRUCTURED IN ADVANCED INSTALLMENTS TO COVER
COSTS THAT
WILL BE INCURRED BY PROJECT

Source text for Eikon:  ID:nBw5TPLQ6a 
Further company coverage:  MEDCL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))